-
EP2298345
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2298345
| EP2298345 - Specific binding members for NGF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 31.01.2014 Database last updated on 15.06.2024 | Most recent event Tooltip | 31.01.2014 | Application deemed to be withdrawn | published on 05.03.2014 [2014/10] | Applicant(s) | For all designated states MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | For all designated states Elan Pharma International Limited Monksland Athlone Westmeath / IE | [2011/12] | Inventor(s) | 01 /
Franks, Ruth MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | 02 /
Buchanan, Andrew, Grier MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | 03 /
Thom, Albert, George MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | 04 /
Welsh, Fraser, Ewing MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | 05 /
Bland-Ward, Philip, Antony MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | 06 /
Sleeman, Matthew, Alexander MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | 07 /
Matthews, Carl, Anthony MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | 08 /
Hart, Celia, Patricia MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | 09 /
Hawkinson, Jon Elan Pharmaceuticals, Inc. 800 Gateway Boulevard South San Francisco CA 94080 / US | [2011/12] | Representative(s) | van der Hoff, Hilary Mary, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2011/12] | King, Hilary Mary, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | Application number, filing date | 10008629.7 | 24.01.2006 | [2011/12] | Priority number, date | US20050645587P | 24.01.2005 Original published format: US 645587 P | [2011/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2298345 | Date: | 23.03.2011 | Language: | EN | [2011/12] | Type: | A3 Search report | No.: | EP2298345 | Date: | 21.03.2012 | Language: | EN | [2012/12] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.02.2012 | Classification | IPC: | C07K16/22, C07K14/48 | [2012/12] | CPC: |
C07K16/22 (EP,KR,NO,US);
A61K39/3955 (NO,US);
A61P11/00 (EP);
A61P11/06 (EP);
A61P17/00 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
A61P29/00 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P9/06 (EP);
C07K14/48 (EP,KR,NO,US);
A61K2039/505 (EP,US);
C07K2317/21 (EP,US);
C07K2317/33 (US);
C07K2317/51 (US);
C07K2317/515 (US);
C07K2317/52 (US);
C07K2317/56 (US);
C07K2317/565 (US);
C07K2317/567 (US);
C07K2317/622 (EP,US);
|
| Former IPC [2011/12] | A61K39/395, A61P25/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2011/12] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | Spezifische Bindungselemente für NGF | [2011/12] | English: | Specific binding members for NGF | [2011/12] | French: | Éléments de liaison spécifiques pour NGF | [2011/12] | Examination procedure | 20.09.2012 | Amendment by applicant (claims and/or description) | 20.09.2012 | Examination requested [2012/44] | 25.03.2013 | Despatch of a communication from the examining division (Time limit: M06) | 05.10.2013 | Application deemed to be withdrawn, date of legal effect [2014/10] | 29.10.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/10] | Parent application(s) Tooltip | EP06701099.1 / EP1846451 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060701099) is 07.05.2008 | Fees paid | Renewal fee | 06.09.2010 | Renewal fee patent year 03 | 06.09.2010 | Renewal fee patent year 04 | 06.09.2010 | Renewal fee patent year 05 | 01.11.2010 | Renewal fee patent year 06 | 25.01.2012 | Renewal fee patent year 07 | 25.01.2013 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO02096458 (GENENTECH INC [US], et al) [X] 1,2,5,6,9,10 * page 3, line 15 - line 31 * * page 13, line 5 - page 22, line 10 * * examples 1-5; claims 1-47 *; | [XP]WO2005019266 (AMGEN INC [US], et al) [XP] 1-11 * page 3, line 18 - line 26 * * page 40, line 14 - page 41, line 7 * * page 50, line 1 - page 51, line 27 ** examples 2-9; claims 1-95 *; | [A] - MCKAY BROWN ET AL, "Tolerance to single, but not multiple, amino acid replacements in antibody V-H CDR2: A means of minimizing B cell wastage from somatic hypermutation?", JOURNAL OF IMMUNOLOGY, AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (19960101), vol. 156, no. 9, ISSN 0022-1767, pages 3285 - 3291, XP002649029 [A] 1-11 * the whole document * |